Cambium Networks Reports Fourth Quarter and Full Year 2020 Financial Results
Record revenues of $82.8 million, increased 13% sequentially, up 29% year-over-year Gross margin of 51.0%,…
Record revenues of $82.8 million, increased 13% sequentially, up 29% year-over-year Gross margin of 51.0%,…
BALA CYNWYD, Pa., Feb. 18, 2021 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome…
STAMFORD, Conn., Feb. 18, 2021 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company…
LAKE FOREST, Ill., Feb. 18, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
HOUSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (Nasdaq:BPTH), a biotechnology company leveraging…
OC-01 (Varenicline) Nasal Spray New Drug Application (NDA) Submitted to the U.S. Food and Drug…
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage…
BOSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a…
Key 2020 events: Jyseleca approved for rheumatoid arthritis (RA) in Europe & Japan Gilead decided…
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using…
Las Vegas, Feb. 18, 2021 (GLOBE NEWSWIRE) — When the mainstream thinks of marijuana, they…
Phase 2/3 trial will enroll approximately 4,000 healthy pregnant women in the U.S., Canada, Argentina,…
NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE) — GBS Inc. (Nasdaq: GBS), a life sciences…
WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a…
SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
WATERTOWN, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage…
ATLANTA, Feb. 18, 2021 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical…
Nyxol and Low-Dose (0.4%) Pilocarpine Combination to Target Improvement in Near Vision in a Presbyopic…